MARY LONG: Open Payments
NPI 1659939387 · MAXWELTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,690 in 73 payments from 11 companies in 2025. Trend: 2023 $588 · 2024 $560 · 2025 $3,690
Speaker / faculty: $2,500Food & beverage: $1,087Travel & lodging: $77Education: $26
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $2,883 |
| Alkermes, Inc. | 12 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $140 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
| Neurocrine BioSciences, Inc. | 4 | $70 |
| Indivior Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, INGREZZA, INVEGA SUSTENNA, COBENFY, VIVITROL.
Industry payments across WV — which companies pay providers there.
